Literature DB >> 16085886

Escherichia coli K1's capsule is a barrier to bacteriophage T7.

Dean Scholl1, Sankar Adhya, Carl Merril.   

Abstract

Escherichia coli strains that produce the K1 polysaccharide capsule have long been associated with pathogenesis. This capsule is believed to increase the cell's invasiveness, allowing the bacteria to avoid phagocytosis and inactivation by complement. It is also recognized as a receptor by some phages, such as K1F and K1-5, which have virion-associated enzymes that degrade the polysaccharide. In this report we show that expression of the K1 capsule in E. coli physically blocks infection by T7, a phage that recognizes lipopolysaccharide as the primary receptor. Enzymatic removal of the K1 antigen from the cell allows T7 to adsorb and replicate. This observation suggests that the capsule plays an important role as a defense against some phages that recognize structures beneath it and that the K1-specific phages evolved to counter this physical barrier.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085886      PMCID: PMC1183359          DOI: 10.1128/AEM.71.8.4872-4874.2005

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  21 in total

1.  Structure and function of a novel coliphage-associated sialidase.

Authors:  Y Machida; K Miyake; K Hattori; S Yamamoto; M Kawase; S Iijima
Journal:  FEMS Microbiol Lett       Date:  2000-01-15       Impact factor: 2.742

2.  Gene 0.3 of bacteriophage T7 acts to overcome the DNA restriction system of the host.

Authors:  F W Studier
Journal:  J Mol Biol       Date:  1975-05-15       Impact factor: 5.469

3.  Inhibition of phage infection by pneumococcus capsule.

Authors:  H P Bernheimer; J G Tiraby
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

4.  Genomic analysis of bacteriophages SP6 and K1-5, an estranged subgroup of the T7 supergroup.

Authors:  D Scholl; J Kieleczawa; P Kemp; J Rush; C C Richardson; C Merril; S Adhya; I J Molineux
Journal:  J Mol Biol       Date:  2004-01-30       Impact factor: 5.469

5.  Staphylococcus aureus cell surface: capsule as a barrier to bacteriophage adsorption.

Authors:  B J Wilkinson; K M Holmes
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

Review 6.  Structure, assembly and regulation of expression of capsules in Escherichia coli.

Authors:  C Whitfield; I S Roberts
Journal:  Mol Microbiol       Date:  1999-03       Impact factor: 3.501

7.  Escherichia coli K bacteriophages. I. Isolation and introductory characterization of five Escherichia coli K bacteriophages.

Authors:  S Stirm
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

8.  Isolation of bacteriophages specific for the K1 polysaccharide antigen of Escherichia coli.

Authors:  R J Gross; T Cheasty; B Rowe
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

9.  Escherichia coli capsule bacteriophages. II. Morphology.

Authors:  S Stirm; E Freund-Mölbert
Journal:  J Virol       Date:  1971-09       Impact factor: 5.103

10.  Expression, mutagenesis and kinetic analysis of recombinant K1E endosialidase to define the site of proteolytic processing and requirements for catalysis.

Authors:  Daniel R Leggate; J Mark Bryant; Maria B Redpath; Denise Head; Peter W Taylor; J Paul Luzio
Journal:  Mol Microbiol       Date:  2002-05       Impact factor: 3.501

View more
  59 in total

1.  Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat.

Authors:  Eric F Donaldson; Aimee N Haskew; J Edward Gates; Jeremy Huynh; Clea J Moore; Matthew B Frieman
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  The genome of bacteriophage K1F, a T7-like phage that has acquired the ability to replicate on K1 strains of Escherichia coli.

Authors:  Dean Scholl; Carl Merril
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

3.  Proteolytic release of the intramolecular chaperone domain confers processivity to endosialidase F.

Authors:  David Schwarzer; Katharina Stummeyer; Thomas Haselhorst; Friedrich Freiberger; Bastian Rode; Melanie Grove; Thomas Scheper; Mark von Itzstein; Martina Mühlenhoff; Rita Gerardy-Schahn
Journal:  J Biol Chem       Date:  2009-02-03       Impact factor: 5.157

Review 4.  Revenge of the phages: defeating bacterial defences.

Authors:  Julie E Samson; Alfonso H Magadán; Mourad Sabri; Sylvain Moineau
Journal:  Nat Rev Microbiol       Date:  2013-08-27       Impact factor: 60.633

Review 5.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Role of K1 capsule antigen in cirrhotic patients with Escherichia coli spontaneous bacterial peritonitis in southern Taiwan.

Authors:  M C Wang; W H Lin; C C Tseng; A B Wu; C H Teng; J J Yan; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-08       Impact factor: 3.267

Review 7.  Mycoviruses: future therapeutic agents of invasive fungal infections in humans?

Authors:  W W J van de Sande; J R Lo-Ten-Foe; A van Belkum; M G Netea; B J Kullberg; A G Vonk
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-02       Impact factor: 3.267

Review 8.  Biofilm control with natural and genetically-modified phages.

Authors:  Amir Mohaghegh Motlagh; Ananda Shankar Bhattacharjee; Ramesh Goel
Journal:  World J Microbiol Biotechnol       Date:  2016-03-01       Impact factor: 3.312

9.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

10.  High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents.

Authors:  Carlos C Goller; Patrick C Seed
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.